Growing community of inventors

Wyckoff, NJ, United States of America

Frances Christy Nelson

Average Co-Inventor Count = 2.05

ph-index = 9

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 677

Frances Christy NelsonGuy A Schiehser (7 patents)Frances Christy NelsonJeremy Ian Levin (6 patents)Frances Christy NelsonJames Ming Chen (4 patents)Frances Christy NelsonArie Zask (4 patents)Frances Christy NelsonRamaswamy Nilakantan (3 patents)Frances Christy NelsonDominick Mobilio (3 patents)Frances Christy NelsonMichael G Kelly (2 patents)Frances Christy NelsonLynne Padilla Greenblatt (2 patents)Frances Christy NelsonAranapakam Mudumbai Venkatesan (1 patent)Frances Christy NelsonMila T Du (1 patent)Frances Christy NelsonYansong Gu (1 patent)Frances Christy NelsonFrances Christy Nelson (21 patents)Guy A SchiehserGuy A Schiehser (40 patents)Jeremy Ian LevinJeremy Ian Levin (60 patents)James Ming ChenJames Ming Chen (37 patents)Arie ZaskArie Zask (34 patents)Ramaswamy NilakantanRamaswamy Nilakantan (4 patents)Dominick MobilioDominick Mobilio (4 patents)Michael G KellyMichael G Kelly (72 patents)Lynne Padilla GreenblattLynne Padilla Greenblatt (9 patents)Aranapakam Mudumbai VenkatesanAranapakam Mudumbai Venkatesan (83 patents)Mila T DuMila T Du (16 patents)Yansong GuYansong Gu (13 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. American Home Products Corporation (12 from 1,567 patents)

2. American Cyanamid Company (6 from 3,580 patents)

3. Wyeth (3 from 1,309 patents)


21 patents:

1. 7470794 - Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors

2. 6825352 - Preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitors

3. 6465508 - Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors

4. 6242448 - Trisubstituted-oxazole derivatives as serotonin ligands

5. 6200996 - Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors

6. 6197795 - Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors

7. 616281 - Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as

8. 6162814 - Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as

9. 6057340 - Oxazole derivatives as serotonin-1A receptor agonists

10. 5962481 - Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as

11. 5929097 - Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix

12. 5559122 - Hindered N-oxide esters of rapamycin

13. 5521194 - Hindered N-oxide esters of rapamycin

14. 5508285 - Hindered N-oxide esters of rapamycin

15. 5508290 - Hindered N-oxide esters of rapamycin

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…